• Carrier-Platin and the ROS Storm in Cancer Cells

  2026-08-25

  Liu et al. describe carrier-platin, a platinum nanotherapeutic that confines ultrasmall platinum-based nanoparticles within a poly(amino acids) carrier to generate a rapid intracellular ROS burst. The resulting cancer-cell death occurs independently of DNA damage and is distinct from canonical apoptosis and ferroptosis, suggesting a strategy for addressing platinum resistance while limiting systemic toxicity.

• 2-NBDG for Cellular Glucose Uptake Assays

  2026-08-24

  2-NBDG converts transporter-mediated glucose uptake into a measurable fluorescent signal for flow cytometry, microscopy, and plate-based profiling. This practical guide shows how to connect that readout to HK2-centered metabolic mechanisms, including the arsenic-induced Warburg phenotype reported in human L-02 hepatocytes.

• Dynamic LRIG1 Expression in Salivary Gland Development

  2026-08-24

  Liu and colleagues combine single-cell RNA sequencing with qRT-PCR, immunofluorescence, and RNAscope to define how Lrig1 expression changes during murine submandibular gland development. Their results place LRIG1 in epithelial and mesenchymal compartments, with notable enrichment in acinar and basal progenitor-associated populations, while complementary human cell-line experiments examine possible effects on proliferation, migration, and transcriptional regulation.

• EdU Imaging Kits (Cy3) for Organoid S-Phase Mapping

  2026-08-23

  EdU Imaging Kits (Cy3) provide precise 5-ethynyl-2'-deoxyuridine imaging kit performance for mapping S-phase DNA synthesis in complex organoids. This guide explains how to convert EdU fluorescence into a spatially informed interpretation of CAF-mediated drug response.

• MG-262 Proteasome Inhibition Workflows

  2026-08-22

  MG-262 enables reversible, cell-permeable proteasome perturbation for linking ubiquitin accumulation with inflammation, cell-cycle arrest, and apoptosis. This workflow translates pulmonary epithelial findings into practical assay designs while highlighting dose, timing, washout, and matrix-specific controls.

• DEV VP26, Actin–Myosin II, and Viral Proliferation

  2026-08-22

  Chen and colleagues combine VP26 interactome profiling with genetic and pharmacological perturbation to identify the host actin–myosin II network as a regulator of duck enteritis virus proliferation. The study highlights MYH9 as a candidate host factor and provides a framework for testing how cytoskeletal organization influences herpesvirus infection.

• JNJ-26481585 (Quisinostat) in Cancer Research

  2026-08-21

  JNJ-26481585, also called Quisinostat, is a second-generation HDAC inhibitor and epigenetic modulator with strong reported activity against class I HDAC enzymes. Product data and a 2025 pituitary adenoma study support its use as a research tool for histone acetylation, apoptosis, cell proliferation assays, TRIM21 biology, and tumor growth inhibition.

• Substrate Stiffness Drives Dentinogenesis via MEK1/2

  2026-08-20

  This study identifies a LAMB1–FAK–MEK1/2 signaling axis that connects substrate stiffness with odontoblast-like cell spreading and dentinogenic differentiation. Its findings provide a mechanistic framework for designing dental biomaterials in which cell–material mechanics are treated as active regulators of reparative dentin formation.

• EZ Cap™ Cy5 EGFP mRNA for LNP Assays

  2026-08-20

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates delivery from translation in one experiment by pairing Cy5 cargo tracking with EGFP protein expression. This dual-readout design helps researchers compare lipid nanoparticles, optimize difficult cell models, and diagnose whether assay failure occurs during uptake, intracellular trafficking, or protein production.

• Tetrazolium (chloride) for Viability & Stroke Assays

  2026-08-19

  Use Tetrazolium (chloride) to convert dehydrogenase activity into a red, spatially resolved formazan signal for cell and ischemic-tissue studies. Its strongest use-case is pairing rapid cellular screening with ex vivo lesion mapping, while orthogonal assays prevent metabolic activity from being mistaken for absolute viability.

• Lysoptosis and Intracellular Serpin Control

  2026-08-19

  The reference study defines lysoptosis as a distinct, cathepsin-dependent lysosomal cell-death pathway and shows that its core features are conserved from Caenorhabditis elegans to mouse and human epithelial models. Its genetic and cell-biological framework clarifies how intracellular serpins restrain lysosomal proteases and provides a model for separating causative lysosomal membrane permeabilization from secondary damage in regulated cell death.

• Dibutyryl-cAMP, sodium salt in Neural Assays

  2026-08-18

  Dibutyryl-cAMP, sodium salt provides a practical way to perturb cAMP-dependent signaling while neural cells differentiate, enabling time-resolved PKA studies and transcriptomic controls. This workflow connects DBcAMP sodium salt exposure with sex-aware human embryonic stem cell models, neuronal glucose uptake inhibition, and reproducible assay troubleshooting.

• Filipin III for Membrane Cholesterol Detection

  2026-08-18

  Filipin III combines sterol-selective membrane binding with fluorescence-based imaging and freeze-fracture ultrastructural analysis. This guide translates its chemistry into practical workflows for cell imaging, membrane fractions, vesicle assays, and macrophage sterol research while highlighting controls that prevent misleading intensity data.

• Tubastatin A: Reading HDAC6 Through Cell Death

  2026-08-17

  Tubastatin A is a selective HDAC6 inhibitor that links α-tubulin acetylation with inflammatory and regulated cell-death readouts. This article translates porcine cardiac-arrest findings into a practical framework for choosing orthogonal assays, controls, and research applications.

• Zoledronic Acid Workflows for Cancer and Bone Models

  2026-08-17

  Build more reliable Zoledronic Acid studies by separating formulation, exposure, apoptosis, and bone-remodeling endpoints. This workflow connects cancer-cell assays with osteolytic disease models while using orthogonal validation strategies inspired by a recent immunometabolic study.

8076 records 9/539 page Previous Next First page 上5页 678910 下5页 Last page